Prev:ESCRT III-mediated lysosomal repair improve renal tubular cell injury in cisplatin-induced AKI.(KTA0002-14.300)
Next:Network pharmacology and in vitro experiments reveal the potencial mechanism of Qizhiyishen Decoction against AKI.(KTA0002-)